Ultragenyx Pharmaceutical Inc. (RARE)

CIK 1515673 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ultragenyx Pharmaceutical Inc..

Recent SEC filings

FiledFormAccession number
Sep 8, 202640001193125-26-384878
Sep 2, 20268-K0001193125-26-380165
Aug 19, 20268-K0001193125-26-357185
Aug 14, 2026SCHEDULE 13G0001493215-26-000161
Aug 13, 2026SCHEDULE 13G0001167557-26-000169
Aug 11, 20268-K0001193125-26-343525
Aug 7, 2026SCHEDULE 13G0000093751-26-000549
Aug 5, 202610-Q0001193125-26-333233
Aug 4, 202640001193125-26-332547
Aug 4, 202640001193125-26-332536
Aug 4, 20268-K0001193125-26-332802
Aug 3, 20261440001950047-26-007510
Jul 31, 2026SCHEDULE 13G/A0002100121-26-001001
Jul 31, 2026SCHEDULE 13G0002100119-26-001487
Jul 30, 2026SCHEDULE 13G/A0002012383-26-003116
Jul 6, 202640001193125-26-296128
Jul 1, 20261440001950047-26-006703
Jun 15, 20261440001950047-26-006115
Jun 15, 202640001677455-26-000002
Jun 15, 20261440001950047-26-006073
Jun 15, 202640001796536-26-000007
Jun 12, 2026S-80001193125-26-269040
Jun 1, 20261440001950047-26-005347
Jun 1, 202640001786335-26-000002
May 18, 202640001193125-26-229224